Researchers develop ultra-high-performance method to analyze oxylipins

Blog
- Aug 10
- 1 min
NDR starts clinical trial with TVALA
- Feb 2
- 1 min
Innovate Indiana recognizes Dr. Chandler Walker for secretome work
- Jan 24
- 1 min
NDR publishes novel study
- Jan 11
- 2 min
Dr. Chandler Walker publishes CTMP data
- Dec 8, 2022
- 1 min
Congratulations to Dr. Susanne Petri and her team!
- Nov 9, 2022
- 1 min
NDR awards Dr. Chandler Walker $1.1 Million for ALS Research
- Nov 7, 2022
- 1 min
Verge Genomics starts Phase I Human trial with VRG50635
- Sep 29, 2022
- 1 min
Ghada Maged receives NDR student award
- Sep 22, 2022
- 1 min
Dr. Chandler Walker moves to final round of IU Idea to Startup Pitch Competition


- Sep 16, 2022
- 1 min
A Personal Message from Dr. Siddique


- Sep 12, 2022
- 1 min
Second Video Installment


- Sep 7, 2022
- 1 min
New Video Series
- Aug 31, 2022
- 1 min
NDR's TVALA® Trademarked
- Aug 17, 2022
- 1 min
Low-cost detection of ALS biomarkers
- Jun 6, 2022
- 1 min
Stealth BioTherapeutics investigates SBT-272 to treat mitochondrial dysfunction in ALS
- May 24, 2022
- 1 min
FDA approves oral edavarone to treat adults living with ALS
- May 9, 2022
- 1 min
Sayuri Miyamoto to present a poster at the Paris Redox 2022 World Conference
- May 4, 2022
- 1 min
Cornerstone for ALS Researchers
- Apr 4, 2022
- 1 min
Research notes from Dr. Miyamoto